Vaginal Mesh Product Liability Issues
Trial Lawyers Demonstrating Experience, Commitment, and Excellence
Cases currently on file detail the complaints of woman who have had mesh
implanted vaginally for the treatment of Pelvic Organ Prolapse (POP) or
Stress Urinary Incontinence (SUI) and suffer from problems such as:
- Urinary problems
- Organ perforation
- Recurrence of original issues
- Issues with intercourse
- Vaginal scarring
- Neuro-muscular problems
At Fibich, Leebron, Copeland & Briggs, our product liability lawyers
are working on the transvaginal mesh litigation and are available to discuss
issues and injuries related to the litigation. If you have any questions
regarding a potential transvaginal mesh claim, contact Fibich, Leebron,
Copeland & Briggs at (713) 489-6566 for more information.
Public Citizen Suggests Recall of Surgical Mesh
Consumer advocacy group Public Citizen petitioned the U.S. Food and Drug
Administration (FDA) on Aug. 25, 2011 to ban the sale of all non-absorbable
surgical mesh products used to transvaginally repair pelvic organ prolapse (POP).
In the petition of Public Citizen the FDA is requested to immediately ban
the sale of all non-absorbable surgical mesh used for transvaginal repair
of POP, and to order all non-absorbable mesh manufacturers to recall the
transvaginal mesh products designed for POP repairs. The petition also
urges the FDA to require all such products be reclassified as a class
III device. This reclassification would require the manufacturers to go
through prospective clinical trials proving the transvaginal mesh would
be safe and effective.
Advocacy groups have said these mesh devices were no more beneficial in
POP surgery than surgery without using the mesh. Transvaginal mesh products
have had high rates of complications which can often require additional
surgery. In some instances the surgeries were unsuccessful and can result
in "life-altering harm" to transvaginal mesh product patients.
Transvaginal Pelvic Mesh Litigation
Lawsuits have been filed regarding the potentially defective transvaginal
pelvic mesh products. Currently, vaginal mesh products are manufactured
by several companies, including Ethicon / Gynecare /Johnson & Johnson
and C.R.Bard, Inc.
The FDA in October 2008 issued warnings to doctors, saying transvaginal
placement of surgical mesh products had triggered more than 1,000 adverse
event reports for such products. The transvaginal pelvic mesh products
are manufactured by at least nine different companies. The most frequent
complications noted by the FDA reports included erosion, infection, pain,
urinary problems, and recurrence of prolapse and / or incontinence, bowel,
bladder, and blood vessel perforation during insertion.
If you, or someone you know, would like to talk with a Fibich, Leebron,
Copeland & Briggs transvaginal mesh litigation attorney, please
at (713) 489-6566.